Citation: Me. Rafestinoblin et B. Couette, ALDOSTERONE RECEPTORS - NEW INSIGHTS IN TRANSDUCTION PATHWAYS OF HORMONAL SIGNAL, Therapie, 53(3), 1998, pp. 227-235
Authors:
ASMAR R
MADONNA O
BRISAC AM
BENETOS A
LAURENT S
Citation: R. Asmar et al., COMPARISON BETWEEN ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS AND ANGIOTENSIN-II ANTAGONISTS, Therapie, 53(3), 1998, pp. 253-270
Citation: M. Burnier et Hr. Brunner, ANGIOTENSIN-II RECEPTOR ANTAGONISTS - CLINICAL DEVELOPMENT AND FUTUREPERSPECTIVES, Therapie, 53(3), 1998, pp. 279-284
Citation: A. Castaigne et S. Benaceraff, RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND HEART-FAILURE - PATHOPHYSIOLOGIC AND THERAPEUTIC ASPECTS, Therapie, 53(3), 1998, pp. 285-289
Citation: M. Andrejak et al., RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITION - PHARMACOLOGICAL RATIONALE AND EVALUATION OF DRUG-COMBINATIONS, Therapie, 53(3), 1998, pp. 291-300
Authors:
GARCIA C
PHILIPPOT P
JOUVE E
BRUGUEROLLE B
BLIN O
Citation: C. Garcia et al., EFFECTS OF ANXIETY ON EMOTIONAL REACTIVITY, PERFORMANCE AND VIGILANCE, IN HEALTHY-VOLUNTEERS, Therapie, 53(3), 1998, pp. 301-308
Citation: D. Dormont, THE NONCONVENTIONAL TRANSMISSIBLE AGENTS AT THE ORIGIN OF TRANSMISSIBLE SUBACUTE SPONGIFORM ENCEPHALOPATHIES, Therapie, 53(2), 1998, pp. 93-100
Authors:
MILLET P
MONNIER B
AFFATON MF
CAMPOCASSO J
ARDITTI J
JOUGLARD J
Citation: P. Millet et al., STUDY OF NARCOTICS AND BUPRENORPHINE SPEC IALITIES PRESCRIPTIONS IN THE PROVENCE-ALPS-COTE DAZUR REGION, Therapie, 53(2), 1998, pp. 107-112
Citation: V. Dubois et al., PHOLY - DRUG UTILIZATION IN CIVIL HOSPICE S OF LYON - A PHARMACOEPIDEMIOLOGIC INVESTIGATION - METHODOLOGY AND DIFFICULTIES, Therapie, 53(2), 1998, pp. 151-155
Citation: 2ND NATIONAL CONGRESS OF FRENCH-SOCIETY-O F-PHARMACOLOGY, NANCY 23-25MARCH 1998 - ABSTRACTS OF PHARMACOVIGILANCE PRESENTATIONS, Therapie, 53(2), 1998, pp. 170-196